246 related articles for article (PubMed ID: 22196973)
1. Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre - results of a 10-year prospective study.
Wiehlmann L; Cramer N; Ulrich J; Hedtfeld S; Weissbrodt H; Tümmler B
Int J Med Microbiol; 2012 Mar; 302(2):69-77. PubMed ID: 22196973
[TBL] [Abstract][Full Text] [Related]
2. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
3. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
Jones AM; Dodd ME; Govan JR; Doherty CJ; Smith CM; Isalska BJ; Webb AK
Am J Respir Crit Care Med; 2005 Feb; 171(3):257-60. PubMed ID: 15542795
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
5. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
[TBL] [Abstract][Full Text] [Related]
7. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
8. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.
Tingpej P; Elkins M; Rose B; Hu H; Moriarty C; Manos J; Barras B; Bye P; Harbour C
Respirology; 2010 Aug; 15(6):923-9. PubMed ID: 20573059
[TBL] [Abstract][Full Text] [Related]
10. A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa.
Festini F; Taccetti G; Galici V; Neri S; Bisogni S; Ciofi D; Braggion C
Am J Infect Control; 2010 Apr; 38(3):244-5. PubMed ID: 20129701
[TBL] [Abstract][Full Text] [Related]
11. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
Bradbury R; Champion A; Reid DW
Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients.
Schelstraete P; Van Daele S; De Boeck K; Proesmans M; Lebecque P; Leclercq-Foucart J; Malfroot A; Vaneechoutte M; De Baets F
Eur Respir J; 2008 Apr; 31(4):822-9. PubMed ID: 18094014
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre.
Van Daele SG; Franckx H; Verhelst R; Schelstraete P; Haerynck F; Van Simaey L; Claeys G; Vaneechoutte M; de Baets F
Eur Respir J; 2005 Mar; 25(3):474-81. PubMed ID: 15738291
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
[TBL] [Abstract][Full Text] [Related]
15. Different opinions of physicians on the importance of measures to prevent acquisition of Pseudomonas aeruginosa from the environment.
Steinkamp G; Ullrich G
J Cyst Fibros; 2003 Dec; 2(4):199-205. PubMed ID: 15463874
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics.
Schmid J; Ling LJ; Leung JL; Zhang N; Kolbe J; Wesley AW; Mills GD; Brown PJ; Jones DT; Laing RT; Pattemore PK; Taylor DR; Grimwood K
Eur Respir J; 2008 Dec; 32(6):1583-90. PubMed ID: 18715877
[TBL] [Abstract][Full Text] [Related]
17. Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis.
Cramer N; Wiehlmann L; Tümmler B
Int J Med Microbiol; 2010 Dec; 300(8):526-33. PubMed ID: 20951087
[TBL] [Abstract][Full Text] [Related]
18. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.
Denton M; Kerr K; Mooney L; Keer V; Rajgopal A; Brownlee K; Arundel P; Conway S
Pediatr Pulmonol; 2002 Oct; 34(4):257-61. PubMed ID: 12205566
[TBL] [Abstract][Full Text] [Related]
19. High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic.
Vosahlikova S; Drevinek P; Cinek O; Pohunek P; Maixnerova M; Urbaskova P; van den Reijden TJ; Dijkshoorn L; Nemec A
Res Microbiol; 2007 May; 158(4):324-9. PubMed ID: 17448645
[TBL] [Abstract][Full Text] [Related]
20. Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis.
Clifton IJ; Peckham DG
Expert Rev Respir Med; 2010 Aug; 4(4):519-29. PubMed ID: 20658913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
